Skip the Antibacterial Soap; Use Plain Soap and Water

by David Randall | Dec 19, 2024 | FDA, RSS

Image EspañolWhen you buy soaps and body washes, do you reach for products labeled “antibacterial” hoping they’ll keep your family safer? Do you think those products will lower your risk of getting sick, spreading germs or being infected?According to the U.S. Food and...

Know When and How to Use Antibiotics, and When to Skip Them

by David Randall | Dec 19, 2024 | FDA, RSS

[embedded content] Español Antibiotics are powerful medications that save countless lives every day. But they’re not the answer for every illness. Antibiotics treat only some infections caused by bacteria – and none caused by viruses. Most often, antibiotics work by...

FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease

by David Randall | Dec 18, 2024 | FDA, RSS

For Immediate Release: December 18, 2024 Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute...

FDA Roundup: December 17, 2024

by David Randall | Dec 17, 2024 | FDA, RSS

For Immediate Release: December 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA posted four warning letters to companies for introducing unapproved GLP-1s, including semaglutide,...

FDA Approves New Drug to Treat Niemann-Pick Disease, Type C

by David Randall | Oct 1, 2024 | RSS

For Immediate Release: September 24, 2024 Today, the U.S. Food and Drug Administration approved Aqneursa (levacetylleucine) for the treatment of neurological symptoms associated with Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing at least...